Free public records show Forma Therapeutics, Inc. in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Forma Therapeutics, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
3 active studies led by Forma Therapeutics, Inc., of 10 in all
Source: ClinicalTrials.gov, Studies with Forma Therapeutics, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
2 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
Studies Forma Therapeutics, Inc. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Forma Therapeutics, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Forma Therapeutics, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Forma Therapeutics, Inc. is in.
Stories on the topics Forma Therapeutics, Inc. works in.
Anaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth…
Read
Iron supplements are the first line against anaemia. Why taking them is the hard part, and how the market is…
Read
Vitamin B12 comes almost only from animal foods. Vegetarians, older adults and people on some medicines are…
ReadSearch all reports for Forma Therapeutics, Inc. All companies